HTFL

Heartflow, Inc. Common Stock NASDAQ Listed Aug 7, 2025

Healthcare ·Medical - Healthcare Information Services ·US · heartflow.com

$29.98

After hrs $29.51 +0.00%

Mkt Cap $2.6B

52w Low $20.13 46.7% of range 52w High $41.22

50d MA $26.58 200d MA $30.13

P/E (TTM) -20.9x

EV/EBITDA -193.2x

P/B 35.1x

Debt/Equity 0.1x

ROE -38.9%

P/FCF -181.9x

RSI (14) —

ATR (14) —

Beta 1.03

50d MA $26.58

200d MA $30.13

Avg Volume 1.6M

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.

SIC Code

3841

CIK (SEC)

1464521

Phone

650-241-1221

331 E. Evelyn Avenue · Mountain View, CA 94041 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 18, 2026	AMC	-0.17	-0.12	+30.8%	25.47	-1.8%	+1.6%	+2.2%	+5.3%	+9.8%	+9.0%	—
Nov 12, 2025	AMC	-0.20	-0.27	-35.0%	35.74	-3.0%	-13.4%	-21.7%	-26.1%	-23.6%	-23.8%	—
Sep 19, 2025	AMC	-0.20	-1.46	-630.0%	32.88	-0.8%	-4.4%	+9.1%	+4.9%	+3.2%	+0.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 4	William Blair	Initiates	Outperform	—	$28.67	$28.99	+1.1%	+1.0%	+4.5%	+5.7%	+4.6%	—
Mar 19	Canaccord Genuity	Maintains	Buy → Buy	—	$25.47	$25.00	-1.8%	+1.6%	+2.2%	+5.3%	+9.8%	+9.0%
Mar 19	JP Morgan	Maintains	Overweight → Overweight	—	$25.47	$25.00	-1.8%	+1.6%	+2.2%	+5.3%	+9.8%	+9.0%
Mar 19	Wells Fargo	Maintains	Overweight → Overweight	—	$25.47	$25.00	-1.8%	+1.6%	+2.2%	+5.3%	+9.8%	+9.0%
Mar 9	Canaccord Genuity	Maintains	Buy → Buy	—	$22.98	$23.09	+0.5%	+0.9%	-1.7%	-3.4%	-9.5%	-10.8%
Nov 13	Canaccord Genuity	Maintains	Buy → Buy	—	$35.74	$34.65	-3.0%	-13.4%	-21.7%	-26.1%	-23.6%	-23.8%
Nov 13	JP Morgan	Maintains	Overweight → Overweight	—	$35.74	$34.65	-3.0%	-13.4%	-21.7%	-26.1%	-23.6%	-23.8%
Nov 13	Stifel	Maintains	Buy → Buy	—	$35.74	$34.65	-3.0%	-13.4%	-21.7%	-26.1%	-23.6%	-23.8%
Sep 22	Canaccord Genuity	Maintains	Buy → Buy	—	$32.88	$32.62	-0.8%	-4.4%	+9.1%	+4.9%	+3.2%	+0.5%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC	—	Sell	56,224	$30.05	$1.7M	8,448,158	-3.66%	+0.74%
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC	—	Sell	892,533	$29.18	$26.0M	8,504,382	-3.66%	+0.74%
Apr 29, 2026	Bain Capital Life Sciences Investors, LLC	—	Sell	797,133	$29.37	$23.4M	9,396,915	-3.66%	+0.74%
Apr 28, 2026	Bain Capital Life Sciences Investors, LLC	—	Sell	254,110	$30.51	$7.8M	10,194,048	-3.66%	+0.74%

Data updated apr 25, 2026 2:13pm · Source: massive.com